GLP-1 Weight Loss in Chattanooga, TN: What Local Clinics Actually Charge (When They'll Say)
Chattanooga's obesity rate against Tennessee's, the state's non-expansion of Medicaid, the one local clinic that publishes an exact price, and a thin endocrinology bench.
36.3% of Chattanooga adults have obesity (CDC PLACES, 2023 data year) 1, just under Tennessee's statewide adult rate of 37.6% (CDC BRFSS, 2023) 2. Chattanooga tracks close to the state average rather than standing out above or below it.
In a city of 191,495 inside a 588,763-person metro, with a median household income of $66,060 and 12.2% uninsured 356, the harder local problem is not the rate. It is that almost nobody here will quote a price.
HRSA's BHW HPSA layers (ArcGIS MapServer at gisportal.hrsa.gov, spatially intersected with downtown Chattanooga, cross-checked against HRSA's own bulk Primary Care HPSA file, BCD_HPSA_FCT_DET_PC.csv, pulled Aug 28, 2026) show a mix of designation types touching Chattanooga, not one uniform type. Primary Care carries 4 active designations: one geographic Low Income Population HPSA ("LI - South Hamilton, Chattanooga", score 9) plus three facility-based FQHC/FQHC-Look-Alike designations named for Chattanooga ("Hamilton County of", FQHC, score 11; "Chattanooga Hamilton County Hospital Authority", FQHC, score 15; "Chattanooga C.A.R.E.S., Inc.", FQHC-Look-Alike, score 17); a separate county-wide "LI-Hamilton County" primary care designation is listed Proposed For Withdrawal. Mental Health: "LI-Hamilton County" is Designated (score 16). Dental: "LI - South Hamilton Chattanooga" is Designated (score 17), with a county-wide dental designation also Proposed For Withdrawal (the Mental Health and Dental figures reflect the original GIS pull and were not independently re-verified against HRSA's bulk CSV in this pass). Net: Chattanooga's shortage designations track low-income and safety-net-facility access gaps specifically, not a general shortage for the commercially-insured population.78
Specialist access
Healthgrades lists 19 endocrinologists within 10 miles of Chattanooga (checked Aug 28, 2026) — a real but thin bench for a metro of roughly 589,000 people, and endocrinology is typically the referral path for GLP-1 prescribing outside primary care. No public source gives actual new-patient wait times for this specialty in Chattanooga (checked directly; not published), so treat "access" here as provider-density evidence, not a verified scheduling-delay claim. HRSA does not track endocrinology under its HPSA program (only primary care, mental health, and dental are designated), so the shortage data above cannot speak to endocrine/obesity-medicine access directly — it's a structural gap in what's measurable, not a finding of adequate access.12
Medicaid coverage note
Tennessee is one of 10 states that has not adopted ACA Medicaid expansion (KFF, live tracker published Aug 21, 2026, checked Aug 28, 2026: "41 states (including DC) have adopted the Medicaid expansion and 10 states have not adopted the expansion," with Tennessee listed "Not adopted"). This research did not verify TennCare's specific formulary/coverage policy for GLP-1s prescribed for weight loss, as opposed to diabetes — flagged as a data gap, not assumed. Separately, HRSA's shortage designations covering Chattanooga are a mix of types (see hpsaSummary): one geographic Low Income Population HPSA plus three facility-based FQHC designations — meaning the documented access gaps here track low-income, uninsured, and safety-net-facility populations specifically, not a general shortage for the commercially-insured population.13
Tennessee's Medicaid position, and the question TennCare hasn't answered
Tennessee is one of 10 states that has not adopted ACA Medicaid expansion. KFF's live tracker, published Aug 21, 2026 and checked Aug 28, 2026, states that "41 states (including DC) have adopted the Medicaid expansion and 10 states have not adopted the expansion," with Tennessee listed "Not adopted" 13.
This research did not verify TennCare's specific formulary or coverage policy for GLP-1s prescribed for weight loss, as opposed to diabetes. That is a flagged data gap, not an assumed no. A Chattanooga resident on TennCare should confirm current coverage with the program or their managed-care plan directly.
What GLP-1 care costs in Chattanooga today
Start with the finding, not the number: of six real GLP-1 clinics checked in the Chattanooga area, four don't publish any dollar figures online. Their semaglutide, tirzepatide, and payment-plan pages contain no dollar figures in the raw page source.
Hixson Weight Loss Center is the exception. At 1008 Executive Dr, Suite 102, it publishes "Starting Price for .25mg $199.00 one shot per week" for semaglutide and "Starting Price for 2.5mg $299.00 one shot per week" for tirzepatide, both with a caveat that prices increase after the first 30 days 10. Its postal address reads Hixson, TN 37343, but the U.S. Census Bureau geocoder confirms the address sits inside Chattanooga's incorporated city limits, GEOID 4714000, the same location ID CDC PLACES uses for Chattanooga 9. At roughly 4.33 weeks per month, the semaglutide starting price alone runs about $862/month, before the clinic's own post-30-day increase.
South Aesthetics has a Chattanooga location at 7200 Shallowford Rd, Suite 101, but publishes only a company-wide range across its three sites: "Price Varies by medication and plan – typically $300–$800/month," with no semaglutide-versus-tirzepatide breakdown and no Chattanooga-specific figure 11. Treat it as directional color, not a clean comparable.
Astra's price is national and flat: $68/month for semaglutide and $118/month for tirzepatide on 12-month plans, $816 and $1,416 billed annually, the same in every city and at every dose.
Nineteen endocrinologists, and shortage designations that track low income
Healthgrades lists 19 endocrinologists within 10 miles of Chattanooga 12, a real but thin bench for a metro of roughly 589,000 people, and endocrinology is typically the referral path for GLP-1 prescribing outside primary care. No public source gives actual new-patient wait times for this specialty here, so this is provider-density evidence, not a verified scheduling-delay claim.
HRSA's designations covering Chattanooga are a mix of types rather than one uniform shortage. Primary care carries one geographic Low Income Population HPSA, "LI - South Hamilton, Chattanooga" (score 9), plus three facility-based FQHC and FQHC-Look-Alike designations named for Chattanooga: "Hamilton County of" (score 11), "Chattanooga Hamilton County Hospital Authority" (score 15), and "Chattanooga C.A.R.E.S., Inc." (score 17) 78. These track low-income and safety-net-facility access gaps specifically, not a general shortage for the commercially-insured population. HRSA does not designate endocrinology at all, so the shortage data cannot speak to obesity-medicine access directly.
Telehealth removes the referral and scheduling step entirely: a licensed prescriber, no local specialist appointment required. See the Tennessee GLP-1 overview for statewide context.
Astra treats patients in Tennessee through state-licensed physicians.
Local options
Hixson Weight Loss Center — 1008 Executive Dr, Suite 102 (postal address reads "Hixson, TN 37343"; the U.S. Census Bureau geocoder — Incorporated Places layer — confirms this address sits inside Chattanooga's incorporated city limits, GEOID 4714000, the same location ID CDC PLACES uses for Chattanooga). Publishes exact starting prices: Semaglutide 0.25mg — "Starting Price for .25mg $199.00 one shot per week" (prices increase after the first 30 days); Tirzepatide 2.5mg — "Starting Price for 2.5mg $299.00 one shot per week" (same 30-day increase caveat). At roughly 4.33 weeks/month, the semaglutide starting price alone (~$862/mo) already runs well above Astra's flat $68/mo national rate — before the clinic's own post-30-day price increase. https://www.hixsonweightloss.net/weight-loss-programs(checked 2026-08-28)
South Aesthetics (Chattanooga location) — 7200 Shallowford Rd, Suite 101, Chattanooga, TN 37421 — one of three South Aesthetics locations (with Kimball, TN and Scottsboro, AL); the site's own descriptive copy names Kimball and Scottsboro but not Chattanooga specifically. Its weight-loss page publishes only a company-wide range, not a Chattanooga-specific figure: "Price Varies by medication and plan – typically $300–$800/month," with no semaglutide-vs-tirzepatide breakdown or dosing detail. A separate "$20" line item next to the Semaglutide/Tirzepatide listing reads as a consult or booking fee, not a drug price. Treat this as directional pricing color, not a clean second comparable to Hixson's specific published starting price. https://www.southaesthetics.com/wellness-treatments/medical-weight-loss(checked 2026-08-28)
Frequently asked questions
Is Astra cheaper than local Chattanooga clinics?
In the one case where a real Chattanooga-area clinic publishes an exact price, yes: Hixson Weight Loss Center's semaglutide starting price is $199/week (about $862/month, before its own 30-day price increase), versus Astra's flat $68/month on a 12-month plan ($816 billed annually). Most other local clinics checked don't publish pricing at all, so a full market comparison isn't possible — but every verified local price found runs several multiples above Astra's national rate.
How much does semaglutide cost in Chattanooga, TN?
Local pricing is mostly hidden: of six real GLP-1 clinics checked in the Chattanooga area, four don't publish any dollar figures online. The one with a specific published price, Hixson Weight Loss Center, lists a semaglutide 0.25mg starting price of $199/week (about $862/month before its own 30-day increase). Astra's semaglutide plan is a flat $68/month on a 12-month plan, billed annually at $816, the same price nationwide.
What is the obesity rate in Chattanooga compared to the rest of Tennessee?
36.3% of Chattanooga adults have obesity (CDC PLACES, 2023 data year), just under Tennessee's statewide adult rate of 37.6% (CDC BRFSS, 2023) — Chattanooga tracks close to the state average rather than standing out above or below it.
Does TennCare or insurance cover GLP-1 medications for weight loss in Tennessee?
Tennessee is one of 10 states that has not adopted ACA Medicaid expansion (KFF, 2026), and this research did not find a verified TennCare formulary policy specifically covering GLP-1s for weight loss, as opposed to diabetes — that's a confirmed data gap, not a yes-or-no answer. Commercial insurance coverage varies by plan and employer.
Why do most Chattanooga weight-loss clinics not list their GLP-1 prices online?
Of six real GLP-1/medical-weight-loss providers checked directly in the Chattanooga area, four require a phone call or booking widget before disclosing any price — their semaglutide, tirzepatide, and payment-plan pages contain no dollar figures in the raw page source. Only Hixson Weight Loss Center publishes a specific starting price; South Aesthetics publishes only a broad, multi-location range that doesn't name Chattanooga specifically.